AAAAAA
Results:
1-18
|
Results: 18
Authors:
Gout, O
Citation: O. Gout, Vaccinations and multiple sclerosis, NEUROL SCI, 22(2), 2001, pp. 151-154
Authors:
Ozden, S
Gessain, A
Gout, O
Mikol, J
Citation: S. Ozden et al., Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy, CLIN INF D, 32(3), 2001, pp. 510-514
Authors:
Gout, O
Ayache, D
Citation: O. Gout et D. Ayache, Susac Syndrome and multiple Sclerosis - Reply, ARCH OTOLAR, 127(4), 2001, pp. 468-468
Authors:
Gout, O
Citation: O. Gout, Vaccinations and multiple sclerosis, N ENG J MED, 344(23), 2001, pp. 1794-1794
Authors:
Marrie, RA
Wolfson, C
Sturkenboom, MCJM
Gout, O
Heinzlef, O
Roullet, E
Abenhaim, L
Citation: Ra. Marrie et al., Multiple sclerosis and antecedent infections: A case-control study - Reply, NEUROLOGY, 56(2), 2001, pp. 283-283
Authors:
Mikaelloff, Y
Moreau, T
Debouverie, M
Pelletier, J
Lebrun, C
Gout, O
Pedespan, JM
Van Hulle, C
Vermersch, P
Ponsot, G
Citation: Y. Mikaelloff et al., Interferon-beta treatment in patients with childhood onset multiple sclerosis, J PEDIAT, 139(3), 2001, pp. 443-446
Authors:
Ureta-Vidal, A
Pique, C
Garcia, Z
Dehee, Z
Tortevoye, P
Desire, N
Gessain, A
Chancerel, B
Gout, O
Lemonnier, FA
Cochet, M
Citation: A. Ureta-vidal et al., Human T cell leukemia virus type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers, J INFEC DIS, 183(6), 2001, pp. 857-864
Authors:
Ayache, D
Plouin-Gaudon, I
Bakouche, P
Elbaz, P
Gout, O
Citation: D. Ayache et al., Microangiopathy of the inner ear, retina, and brain (Susac syndrome) - Report of a case, ARCH OTOLAR, 126(1), 2000, pp. 82-84
Susac's syndrome: improvement with combined cyclophosphamide and intravenous immunoglobulin therapy.
Authors:
Papeix, C
Laloum, L
Richet, A
Ayache, D
Moulignier, A
Heran, F
Bakouche, P
Gout, O
Citation: C. Papeix et al., Susac's syndrome: improvement with combined cyclophosphamide and intravenous immunoglobulin therapy., REV NEUROL, 156(8-9), 2000, pp. 783-785
Authors:
Touze, E
Gout, O
Verdier-Taillefer, MH
Lyon-Caen, O
Alperovitch, A
Citation: E. Touze et al., First central nervous system demyelination and hepatitis B vaccination: a pilot case control study., REV NEUROL, 156(3), 2000, pp. 242-246
Authors:
Marrie, RA
Wolfson, C
Sturkenboom, MCJM
Gout, O
Heinzlef, O
Roullet, E
Abenhaim, L
Citation: Ra. Marrie et al., Multiple sclerosis and antecedent infections - A case-control study, NEUROLOGY, 54(12), 2000, pp. 2307-2310
Authors:
Cavrois, M
Gessain, A
Gout, O
Wain-Hobson, S
Wattel, E
Citation: M. Cavrois et al., Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells, J INFEC DIS, 182(4), 2000, pp. 1044-1050
Authors:
Pique, C
Ureta-Vidal, A
Gessain, A
Chancerel, B
Gout, O
Tamouza, R
Agis, F
Dokhelar, MC
Citation: C. Pique et al., Evidence for the chronic in vivo production of human T cell leukemia virustype I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides, J EXP MED, 191(3), 2000, pp. 567-572
Authors:
Gout, O
Bonnaud, I
Weill, S
Moulignier, A
Quenet, JJ
Moret, J
Bakouche, P
Citation: O. Gout et al., Facial diplegia complicating a bilateral interval carotid artery dissection, STROKE, 30(3), 1999, pp. 681-686
Authors:
Tourbah, A
Stievenart, JL
Gout, O
Fontaine, B
Liblau, R
Lubetzki, C
Cabanis, EA
Lyon-Caen, O
Citation: A. Tourbah et al., Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis, NEUROLOGY, 53(5), 1999, pp. 1091-1097
Authors:
Tourbah, A
Gout, O
Liblau, R
Lyon-Caen, O
Bougniot, C
Iba-Zizen, MT
Cabanis, EA
Citation: A. Tourbah et al., Encephalitis after hepatitis B vaccination - Recurrent disseminated encephalitis or MS?, NEUROLOGY, 53(2), 1999, pp. 396-401
Authors:
Gout, O
Viala, K
Lyon-Caen, O
Citation: O. Gout et al., Giant cell arteritis and Vernet's syndrome - Reply, NEUROLOGY, 52(3), 1999, pp. 677-677
Authors:
Weber, J
Taylor, G
Chieco-Bianchi, L
de The, G
Weiss, R
Goubau, P
Ebbesen, P
Gessain, A
Ozden, S
Brahic, M
Dokhelar, MC
Guillemain, B
von der Helm, K
Bertazzoni, U
Liso, V
Varnier, O
Saracco, A
Huisman, JG
Bangham, CRM
Catovsky, D
Matutes, E
Dalgleish, A
Lever, AML
Mortimer, P
Tosswill, J
Noone, A
Schulz, T
Vandamme, AM
Carton, H
Willems, L
Kirkhofs, P
Wantzin, P
Christiansen, CB
Hall, W
Mamoun, R
Coste, J
Hermine, O
Gout, O
Dodon, MD
Wattel, E
Desgranges, C
Giraudon, P
Pauli, G
Niewiesk, S
Kucherer, C
Khazaie, K
Grassmann, R
Hatzakis, A
Casoli, C
Wicks, R
Manca, F
Galli, M
Ferrante, P
Boeri, E
Lillo, F
Macchi, B
Avillez, F
Caetano, M
Soriano, V
Illa, I
Horal, P
Andersson, S
Krook, A
Daenke, S
Breuer, J
Kelsey, S
Nightingale, S
Pagliuca, T
Bain, B
Brighty, D
Rudge, P
Ades, T
Cann, AJ
Citation: J. Weber et al., The HTLV European Research Network (HERN) Steering Committee, BIOM HLTH R, 24, 1998, pp. 266-271
Risultati:
1-18
|